Kyverna Therapeutics, Inc.

NASDAQ:KYTX

Biotechnology

Healthcare
$4.48 -1.44%

-$0.12 today

Market cap
$283.23M
Beta
1.96
P/E (TTM)
-3.1
EPS (TTM)
-$2.59
52W Low $2.52High $13.67

Volume 1.05M

Average 0.94M

Price history

Kyverna Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-45.57%

Period high

$11.25

Period low

$4.48

Latest

$4.48

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
SC 13GOct 19, 2026Oct 19, 2026
8-KSep 24, 2026Sep 24, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
10-QAug 11, 2026Aug 11, 2026
8-KAug 11, 2026Aug 11, 2026
SC 13GJul 29, 2026Jul 29, 2026
8-KJul 27, 2026Jul 27, 2026
8-KJul 9, 2026Jul 9, 2026
8-KJun 2, 2026Jun 2, 2026
4May 29, 2026May 29, 2026
4May 29, 2026May 29, 2026
4May 29, 2026May 29, 2026
4May 29, 2026May 29, 2026

Competitors

Who does Kyverna Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about KYTX's filings, answered from its disclosures.

What is the latest KYTX filing?

The latest filing shown is 8-K dated Nov 12, 2026.

How many recent filings does KYTX have?

Intrinsic Alpha currently shows 20 recent filings for KYTX.